Journal of Neuroscience, Vol 7, 1902-1910, Copyright © 1987 by Society for Neuroscience
Identification, characterization, and developmental regulation of embryonic benzodiazepine binding sites
LA Borden, TT Gibbs and DH Farb
We report the identification and characterization of 2 classes of
benzodiazepine binding sites in the embryonic chick CNS. Binding was
examined by competition and saturation binding experiments, using as
radioligands 3H-flunitrazepam, a classical benzodiazepine anxiolytic, and
3H-Ro5-4864, a convulsant benzodiazepine. The results demonstrate that
high-affinity (KD = 2.3 nM) 3H-flunitrazepam binding sites (site- A) are
present by embryonic day 5 (Hamburger and Hamilton stage 27) and increase
throughout development (Bmax = 0.3 and 1.3 pmol/mg protein in 7 and 20 d
brain membranes, respectively). When 7 or 20 d brain membranes are
photoaffinity-labeled with 3H-flunitrazepam and ultraviolet light, the
radioactivity migrates as 2 bands on SDS-PAGE, consistent with Mrs of
48,000 and 51,000. GABA potentiates 3H- flunitrazepam binding at both 7 and
20 d of development, indicating that site-A is coupled to receptors for
GABA early in development. Importantly, we have also identified a novel
site (site-B) that binds classical benzodiazepine agonists with low
affinity (micromolar) but displays high affinity for Ro5-4864 (KD = 41 nM).
Site-B displays characteristics expected for a functional receptor,
including stereospecificity and sensitivity to inactivation by heat and
protease treatment. Saturation binding studies employing 3H-Ro5-4864
indicate that the levels of site-B are similar in 7 and 20 d brain (ca. 2.5
pmol/mg protein). The function of site-B is not known, but its
preponderance in 7 d brain, relative to site-A, suggests that it might be
important during early embryonic development.